$61.01
▲ $1.10 (+1.8%)
BMRN
BioMarin Pharmaceutical Inc. Common Stock
Health Care
Investor Score
65B-
Moderate rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
77
Technical
59
Fundamental
51
Growth
62
Fair Value
86
News
58
Quality
56
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.